LYC Healthcare Berhad provides health care services primarily in Malaysia and Singapore. The company operates through three segments: Healthcare Services, Computing and Electronic Services, and Other segments. It engages in the provision of mother and childcare related services, such as postnatal and postpartum care, post-delivery confinement care, and aesthetics; healthcare related services; cosmetics related and medical aesthetic treatment services; dental treatment and consultancy; child daycare; and medical and surgical advisory services, as well as deals in raw and finished, consumable and non-consumable food ingredients. The company also offers research and development; e-manufacturing solutions and IT outsourcing services; and computer and its related products. In addition, it provides business management consultant services; infrastructure for hosting and data processing services; general medical and prostate cancer treatment services; personal care, wellness, and promotion/management services; manufactures food and health supplements; and other food products export and import services, as well as retails various products through internet. In addition, it manufactures, wholesales, and retails nutraceuticals, pharmaceutical, and healthcare products. The company was formerly known as Mexter Technology Berhad and changed its name to LYC Healthcare Berhad in January 2019. LYC Healthcare Berhad was founded in 1992 and is headquartered in Kuala Lumpur, Malaysia.
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
The market has been flat over the last week. As for the longer term, the market has also been flat over the past year. Earnings are forecast to grow by 9.9% annually. Market details ›